XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
 [1]
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock Issued
Common Stock Issued
Cumulative Effect, Period of Adoption, Adjusted Balance
 Additional Paid-in  Capital
 Additional Paid-in  Capital
Cumulative Effect, Period of Adoption, Adjustment
 [1]
 Additional Paid-in  Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
 Retained Earnings
 Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
 [1]
 Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
 Non-Controlling Interest
 Non-Controlling Interest
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning Balance (in shares) at Dec. 31, 2019       47,749                          
Beginning balance at Dec. 31, 2019 $ 1,927,745     $ 477   $ 675,060     $ (115,449)   $ (172,342)   $ 1,530,614     $ 9,385  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Stock issued (in shares)       189                          
Stock issued 1,952     $ 2   1,950                      
Share repurchases for tax withholdings (8,817)         (8,817)                      
Stock-based compensation expense 12,533         12,533                      
Change in value of redeemable non-controlling interest (2,624)                       (2,624)        
Foreign currency translation (41,404)               (40,935)             (469)  
Net (loss) income (12,411)                       (13,632)     1,221  
Ending Balance (in shares) at Mar. 31, 2020       47,938                          
Ending balance at Mar. 31, 2020 1,876,974     $ 479   680,726     (156,384)   (172,342)   1,514,358     10,137  
Beginning Balance (in shares) at Dec. 31, 2019       47,749                          
Beginning balance at Dec. 31, 2019 1,927,745     $ 477   675,060     (115,449)   (172,342)   1,530,614     9,385  
Ending Balance (in shares) at Dec. 31, 2020       48,616 48,616                        
Ending balance at Dec. 31, 2020 1,917,917 $ (40,006) $ 1,877,911 $ 485 $ 485 872,711 $ (41,982) $ 830,729 (82,935) $ (82,935) (172,342) $ (172,342) 1,286,976 $ 1,976 $ 1,288,952 13,022 $ 13,022
Beginning Balance (in shares) at Mar. 31, 2020       47,938                          
Beginning balance at Mar. 31, 2020 1,876,974     $ 479   680,726     (156,384)   (172,342)   1,514,358     10,137  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Stock issued (in shares)       5                          
Stock issued 184         184                      
Share repurchases for tax withholdings (76)         (76)                      
Stock-based compensation expense 14,219         14,219                      
Change in value of redeemable non-controlling interest 59,940                       59,940        
Foreign currency translation 23,344               23,123             221  
Net (loss) income 13,294                       12,718     576  
Ending Balance (in shares) at Jun. 30, 2020       47,943                          
Ending balance at Jun. 30, 2020 1,987,879     $ 479   695,053     (133,261)   (172,342)   1,587,016     10,934  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Stock issued (in shares)       30                          
Stock issued 2,091         2,091                      
Fair value of stock issued through private placement (in shares)       577                          
Fair value of stock issued through private placement, net of issuance costs of $968 92,976     $ 6   92,970                      
Share repurchases for tax withholdings (378)         (378)                      
Equity component of the convertible notes 41,066         41,066                      
Stock-based compensation expense 17,882         17,882                      
Change in value of redeemable non-controlling interest (6,879)                       (6,879)        
Transfer of cumulative translation adjustment on the sale of subsidiary 5,473               5,473                
Foreign currency translation 15,147               14,715             432  
Net (loss) income (58,254)                       (58,961)     707  
Ending Balance (in shares) at Sep. 30, 2020       48,550                          
Ending balance at Sep. 30, 2020 2,097,003     $ 485   848,684     (113,073)   (172,342)   1,521,176     12,073  
Beginning Balance (in shares) at Dec. 31, 2020       48,616 48,616                        
Beginning balance at Dec. 31, 2020 1,917,917 $ (40,006) $ 1,877,911 $ 485 $ 485 872,711 $ (41,982) $ 830,729 (82,935) $ (82,935) (172,342) $ (172,342) 1,286,976 $ 1,976 $ 1,288,952 13,022 $ 13,022
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Stock issued (in shares)       394                          
Stock issued 22,559     $ 4   22,555                      
Share repurchases for tax withholdings (21,062)         (21,062)                      
Stock-based compensation expense 17,886         17,886                      
Change in value of redeemable non-controlling interest (25,044)                       (25,044)        
Foreign currency translation (6,877)               (6,558)             (319)  
Net (loss) income 22,853                       22,479     374  
Ending Balance (in shares) at Mar. 31, 2021       49,010                          
Ending balance at Mar. 31, 2021 1,888,226     $ 489   850,108     (89,493)   (172,342)   1,286,387     13,077  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Stock issued (in shares)       214                          
Stock issued 20,481     $ 2   20,479                      
Share repurchases for tax withholdings (884)         (884)                      
Stock-based compensation expense 20,629         20,629                      
Acquisition of non controlling interest (96,992)         (81,631)     (2,284)             (13,077)  
Change in value of redeemable non-controlling interest (43,823)                       (43,823)        
Foreign currency translation (2,682)               (2,682)                
Net (loss) income 9,967                       9,967        
Ending Balance (in shares) at Jun. 30, 2021       49,224                          
Ending balance at Jun. 30, 2021 1,794,922     $ 491   808,701     (94,459)   (172,342)   1,252,531     0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Stock issued (in shares)       21                          
Stock issued 704         704                      
Share repurchases for tax withholdings (1,066)         (1,066)                      
Stock-based compensation expense 21,735         21,735                      
Change in value of redeemable non-controlling interest (3,416)                       (3,416)        
Foreign currency translation (20,368)               (20,368)                
Net (loss) income 51,734                       51,734        
Ending Balance (in shares) at Sep. 30, 2021       49,245                          
Ending balance at Sep. 30, 2021 $ 1,844,245     $ 491   $ 830,074     $ (114,827)   $ (172,342)   $ 1,300,849     $ 0  
[1] Reflects the impact of the Company’s modified retrospective adoption of ASU 2020-06 (See Note 1, Basis of Presentation).